Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-10-27 Chen Hongming CHIEF SCIENTIFIC OFFICER Sale −21,051 $1.82 $38K 204,515
2021-10-26 Chen Hongming CHIEF SCIENTIFIC OFFICER Sale −9,449 $1.80 $17K 225,566
2021-06-29 Chen Hongming CHIEF SCIENTIFIC OFFICER Sale −5,548 $5.56 $31K 235,015
2021-06-28 Chen Hongming CHIEF SCIENTIFIC OFFICER Sale −2,452 $5.77 $14K 240,563
2021-03-01 Chen Hongming Chief Scientific Officer Exercise or conversion +9,500 $2.30 $22K 243,015
2021-03-01 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy −9,500 53,736
2021-02-25 Chen Hongming Chief Scientific Officer Exercise or conversion +47,000 $2.30 $108K 233,515
2021-02-25 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −47,000 63,236
2021-01-04 Chen Hongming Chief Scientific Officer Grant or award +22,666 186,515
2021-01-04 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +90,667 90,667
2020-10-26 Chen Hongming Chief Scientific Officer Grant or award +61,000 163,849
2020-06-25 Chen Hongming Chief Scientific Officer Grant or award +16,000 102,849
2020-03-30 Chen Hongming Chief Scientific Officer Exercise or conversion +31,000 $2.30 $71K 86,849
2020-03-30 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −31,000 75,236
2020-01-02 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +120,000 120,000
2019-01-02 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2018-02-28 Chen Hongming Chief Scientific Officer Exercise or conversion +4,000 $2.30 $9K 50,080
2018-02-28 Chen Hongming Chief Scientific Officer Exercise or conversion +5,769 $2.24 $13K 55,849
2018-02-28 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −4,000 106,236
2018-02-28 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −5,769 0

Page 1 of 2 · 22 trades